Cardiac failure in patients treated with azacitidine a pyrimidine analogue: Case reports and disproportionality analyses in Vigibase

摘要

Azacitidine (AZA), a pyrimidine analogue, is validated for high‐risk myelodysplastic syndrome or low‐blast acute myeloid leukaemia in unfit patients for more intensive treatment. This study assessed the putative link between cardiac failure (CF) and AZA exposure.